The HPV vaccine is one of the most expensive routine vaccines in the United States, which makes the cash price in 2026 a real barrier for uninsured families and adults. Gardasil 9, made by Merck, is the only HPV vaccine sold in the U.S., and the CDC 2026 vaccine price list shows a private-sector price of $329.09 per dose before any clinic or pharmacy markup. The Advisory Committee on Immunization Practices (ACIP), not the U.S. Preventive Services Task Force, sets coverage rules for vaccines, so the HPV vaccine is not a USPSTF preventive service even though ACA-compliant plans cover it at no cost. ACIP recommends routine vaccination at ages 11 to 12, with catch-up through age 26 and shared clinical decision-making for ages 27 to 45.
Total cost depends on the number of doses and the site of care. Patients who start the series before their 15th birthday traditionally need 2 doses, while those who start at 15 or older, and people with weakened immune systems, need 3 doses. In January 2026 the CDC revised its childhood schedule to recommend a single HPV dose at age 11, a change made without an ACIP vote and questioned by groups including ACOG and the American Academy of Pediatrics. Because the FDA label and many clinicians still describe a multi-dose series, patients should ask their clinic and insurer which schedule applies before booking. Medicare Advantage and Original Medicare members are rarely in the target age range, so this page focuses on uninsured, ACA-compliant plan, and Medicaid situations.
HPV vaccine pricing without insurance in 2026, broken down by site of care and age group, appears below, along with what Medicare Part D and ACA-compliant plans pay, how to request a Good Faith Estimate under the No Surprises Act, and the free and discounted programs, including the CDC Vaccines for Children program and the Merck patient assistance program, that can bring the cost to $0. Billing-error patterns specific to vaccine claims are also covered, since a vaccine that should carry a $0 copay is often billed with one.
HPV Vaccine Cost by Site of Service in 2026
The biggest cost driver of HPV Vaccine is the site of service: where the procedure is performed. 2026 CMS price transparency data confirms a 2-3x billing differential between independent centers and hospital outpatient departments.
HPV Vaccine prices without insurance vs. 2026 Medicare rates| Site of Service | Range Without Insurance | 2026 Medicare Rate |
|---|
| Retail pharmacy (CVS, Walgreens, Walmart, Rite Aid) | $300 to $450 per dose | Medicare Part D plan, $0 patient cost-sharing |
| Primary care or pediatric office | $320 to $500 per dose | Medicare Part D plan, $0 patient cost-sharing |
| Urgent care or retail clinic | $350 to $520 per dose | Medicare Part D plan, $0 patient cost-sharing |
| Public health department or FQHC clinic | $0 to $200 per dose | Medicare Part D plan, $0 patient cost-sharing |
| Hospital outpatient department | $400 to $600 per dose | Medicare Part D plan, $0 patient cost-sharing |
HPV vaccine cost chart by site of service 2026. Ranges are per dose and include the administration fee. They are estimates built from the CDC 2026 vaccine price list ($329.09 private-sector price per dose), retail pharmacy rate cards, and FAIR Health Consumer data, and they vary by ZIP code. Medicare Part B does not pay for this vaccine; Medicare Part D plans cover it with no patient cost-sharing for ACIP-recommended adult doses.
Source: CDC Vaccine Price List 2026, FAIR Health Consumer 2026, retail pharmacy published rate cards, KFF Immunization Coverage Analysis
Why the Same Procedure Is So Much More at a Hospital
The 2026 HPV vaccine cost is driven mostly by the price of the vaccine itself, not by the site, so the site-of-service spread is narrower than for imaging or surgery. The CDC 2026 private-sector list price of $329.09 per dose sets a floor for any clinic that buys the vaccine on the commercial market, and clinics add an administration fee and a margin on top. Retail pharmacies and public clinics sit at the low end of the 2026 range, physician offices and urgent care sit in the middle, and hospital outpatient departments sit at the high end because they bill from a facility chargemaster and may add a facility fee or an evaluation charge.
The chargemaster is the hospital's internal list price, which insured patients rarely pay in full but uninsured patients are sometimes billed at face value. Hospital policies often allow a self-pay discount of 20 to 60 percent in 2026 if the patient asks, and a vaccine is a poor use of a hospital outpatient visit when a pharmacy or public clinic stocks the same Gardasil 9 product. Public health departments and Federally Qualified Health Centers (FQHCs) may buy vaccine at CDC contract prices of about $275 per dose or receive it through federal programs, which is why their patient charges can fall to $0 to $200.
Cash-pay patients in 2026 should price the vaccine at two or three sites before booking, and should ask whether the quoted figure includes the administration fee. A retail pharmacy visit is usually the cheapest option for adults, while pediatric offices and public health clinics are the usual route for children and teens, where the Vaccines for Children program can make the dose free.
HPV Vaccine Series Cost by Age Group in 2026
The number of Gardasil 9 doses depends on the age at the first dose and on immune status, and every extra dose adds roughly $300 to $450 to the 2026 cash price. The table below shows the traditional ACIP series and the cash cost of each, with the coverage status of each group.
Typical cost by variant| Age Group | Doses (Traditional Series) | Total Cash Cost Without Insurance (2026) | Insurance Cost (2026) |
|---|
| Ages 9 to 14, started before 15th birthday | 2 doses, 6 to 12 months apart | $600 to $900 | $0 on ACA-compliant plans; free through Vaccines for Children if eligible |
| Ages 15 to 26, catch-up | 3 doses over 6 months | $900 to $1,350 | $0 on ACA-compliant plans and Medicaid |
| Ages 27 to 45, shared clinical decision-making | 3 doses over 6 months | $900 to $1,350 | $0 on ACA-compliant plans when the clinician recommends it |
| Any age with weakened immune system | 3 doses over 6 months | $900 to $1,350 | $0 on ACA-compliant plans |
| Age 11 under the January 2026 CDC single-dose schedule | 1 dose | $300 to $450 | $0 on ACA-compliant plans; confirm extra doses with your insurer |
Totals multiply the 2026 per-dose range of $300 to $450 by the number of doses. The CDC revised its childhood schedule in January 2026 to recommend one dose at age 11, but the FDA label and several medical societies still describe a multi-dose series, so ask your clinic which schedule it follows.
Source: CDC ACIP HPV Vaccine Recommendations, CDC Vaccine Price List 2026, retail pharmacy rate cards
What Medicare Pays for HPV Vaccine
Original Medicare Part B does not cover the HPV vaccine, because Part B pays only for a short list of vaccines such as flu, pneumococcal, hepatitis B for higher-risk people, and COVID-19. The 2026 Part B deductible of $283 and the 20 percent coinsurance therefore do not apply, and the Medicare Physician Fee Schedule has no payment rate for the product, so the pricing field on this page shows $0. Medicare Part D plans, including Medicare Advantage plans with drug coverage, cover ACIP-recommended adult vaccines with no deductible and no cost-sharing since the Inflation Reduction Act took effect January 1, 2023. Medigap does not cover Part D drugs. Few Medicare members fall in the 9 to 45 age range, but people under 65 on Medicare because of disability can use the Part D benefit. Details are at medicare.gov.
ACA-compliant plan coverage is the main route to a $0 HPV vaccine in 2026. Under Section 2713 of the Affordable Care Act, marketplace and employer plans must cover ACIP-recommended immunizations in-network with no copay, no coinsurance, and no deductible, even on a high-deductible plan. The HPV vaccine is not a USPSTF-graded screening service, but ACIP recommendations carry the same no-cost-sharing rule, as explained at healthcare.gov. Prior authorization is not normally required. Out-of-network clinics, extra same-day services, and doses outside the plan's recognized schedule can still produce a bill. Medicaid covers recommended adult vaccines at $0 as well, and Medicaid children receive the vaccine through Vaccines for Children.
The No Surprises Act, effective January 1, 2022, gives every uninsured or self-pay patient the right to a written Good Faith Estimate before a scheduled service. For an HPV vaccine visit scheduled at least 10 business days out, the provider must furnish the Good Faith Estimate at least 3 business days before the visit. For an appointment scheduled 3 to 9 business days out, the Good Faith Estimate is due at least 1 business day before. Visits scheduled less than 3 business days out do not require an advance estimate, but the patient can still ask for one. The federal portal at cms.gov/nosurprisesact has full consumer guidance. Walk-in pharmacy shots with a posted price usually fall outside the scheduling rule.
To request a Good Faith Estimate for an HPV vaccine in 2026, follow these steps: (1) Call the clinic, pediatric office, or pharmacy and identify yourself as self-pay or uninsured. (2) Ask for a written Good Faith Estimate that lists the vaccine product, the administration fee, any office-visit charge, and the codes used. (3) Provide your ZIP code and the number of doses you expect to need. (4) Confirm the timing: 3 business days before service if scheduled 10 or more business days out, 1 business day before if scheduled 3 to 9 business days out. (5) Keep the written estimate; if the final bill exceeds it by $400 or more, you have 120 days from the bill date to file a patient-provider dispute resolution claim at cms.gov/nosurprisesact.
A Good Faith Estimate for an HPV vaccine is not a guaranteed final bill. Common reasons the actual charge exceeds the estimate include an office-visit evaluation charge added at a well-child or physician visit, a facility fee when the dose is given at a hospital outpatient department, extra vaccines given at the same visit, and a second or third dose billed at a different price than the first. If the final bill exceeds the Good Faith Estimate by $400 or more, the patient has 120 days from the bill date to file a dispute at cms.gov/nosurprisesact, and the provider cannot send the bill to collections while the dispute is pending.
What Factors Affect Cost
- Site of care is a major 2026 cost factor: retail pharmacies and public clinics charge $0 to $450 per dose, while hospital outpatient departments bill from a chargemaster and can reach $600 per dose.
- Number of doses matters most: 1 dose under the January 2026 CDC schedule, 2 doses when the series starts before age 15, and 3 doses for ages 15 and older or immunocompromised patients, so the total ranges from about $300 to $1,350 in 2026.
- Insurance status: ACA-compliant plans and Medicaid cover ACIP-recommended doses at $0, Medicare Part D plans cover adult doses with no cost-sharing, Original Medicare Part B does not cover the vaccine, and uninsured patients pay the full cash price.
- CDC's Vaccines for Children (VFC) program supplies free HPV vaccine to children ages 9 through 18 who are uninsured, underinsured, Medicaid-enrolled, or American Indian or Alaska Native, through enrolled pediatric offices and health departments.
- Manufacturer and public programs: Merck runs a patient assistance program that can provide Gardasil 9 free to eligible uninsured adults based on income, and local health departments funded by CDC Section 317 grants offer free or low-cost adult doses where funding allows.
- Hospital chargemaster discount ask: most hospitals publish a self-pay discount policy of 20 to 60 percent off chargemaster prices in 2026, and some apply it only when the uninsured patient requests it.
- Sliding-scale pricing at Federally Qualified Health Centers (FQHCs) can bring the cost to $0 for patients below 100 percent of the Federal Poverty Level; see the federal poverty level page for 2026 thresholds.
- Independent clinic and pharmacy cash bundles: some clinics and membership-based direct-pay practices quote one price for the vaccine plus administration, often 10 to 30 percent below the hospital cash price, and a same-day payment can earn a further discount.
Common HPV Vaccine Billing Errors
HPV vaccine billing errors are common because insurers must apply $0 cost-sharing but claim systems do not always do so. Check for these errors in 2026:
- A copay or coinsurance charged for an in-network HPV dose on an ACA-compliant plan, when ACIP-recommended vaccines must carry $0 cost-sharing. Ask the insurer to reprocess the claim.
- A full office-visit evaluation charge billed alongside the vaccine when the only service performed was the injection. Request an itemized bill and ask for the charge to be removed.
- The vaccine product and the administration fee billed as separate claims that each create a patient responsibility line.
- A Vaccines for Children dose billed to the family even though the vaccine was supplied free by the program; only a small administration fee may be charged.
- A second or third dose denied as not medically necessary because the plan recognizes a different schedule, such as the January 2026 single-dose schedule. Ask the clinic to submit documentation and request an appeal if the dose followed the FDA-labeled series.
- A facility fee added for a vaccine given at a hospital outpatient department when the same dose was available at a pharmacy or public clinic for far less.
Frequently Asked Questions
How much does the HPV vaccine cost without insurance in 2026?
The HPV vaccine (Gardasil 9) costs about $300 to $450 per dose without insurance in 2026, with a national median near $350 including the administration fee. The CDC 2026 private-sector list price for the vaccine alone is $329.09 per dose. A 2-dose series runs about $600 to $900 and a 3-dose series about $900 to $1,350. Retail pharmacies and public health clinics are usually cheapest, while hospital outpatient departments can reach $600 per dose. Free programs, including Vaccines for Children and the Merck patient assistance program, can lower the cost to $0 for eligible patients.
What does Medicare pay for the HPV vaccine in 2026?
Original Medicare Part B does not pay for the HPV vaccine, so the 2026 Part B deductible of $283 and the 20 percent coinsurance do not apply. Medicare Part D plans, including Medicare Advantage plans with drug coverage, cover ACIP-recommended adult vaccines with no deductible and no cost-sharing under the Inflation Reduction Act, effective January 1, 2023. Medigap does not cover Part D drugs. Because the vaccine is recommended mainly for ages 9 to 45, few Medicare members need it, but people under 65 on Medicare because of disability can use the Part D benefit.
How do I request a Good Faith Estimate for an HPV vaccine?
Call the clinic, pediatric office, or pharmacy and identify yourself as self-pay or uninsured. Ask for a written Good Faith Estimate that itemizes the vaccine product, the administration fee, and any office-visit charge, and give your ZIP code and the number of doses you expect. Providers must furnish the Good Faith Estimate at least 3 business days before service if scheduled 10 or more business days out, or 1 business day before if scheduled 3 to 9 days out. Keep it; a final bill $400 or more above the estimate can be disputed within 120 days at cms.gov/nosurprisesact.
What is the No Surprises Act and does it apply to me?
The No Surprises Act, effective January 1, 2022, protects uninsured and self-pay patients from surprise bills and guarantees a written Good Faith Estimate before a scheduled service. It applies to an HPV vaccine booked as an appointment at a physician's office, clinic, or hospital, though usually not to a walk-in pharmacy shot with a posted price. It does not cover Medicare or Medicaid patients, who have separate protections. If the final bill exceeds the Good Faith Estimate by $400 or more, the patient-provider dispute process at cms.gov/nosurprisesact allows a claim within 120 days of the bill date.
How do I get a written cash-pay quote for the HPV vaccine?
Call the pharmacy, clinic, or physician's office before your visit and ask for the self-pay price per dose, and whether it includes the administration fee. Ask how many doses the clinic expects you to need and whether it follows the 1-dose, 2-dose, or 3-dose schedule, since that changes the total by hundreds of dollars. At a physician's office, request the price in writing as a Good Faith Estimate. Compare at least two sites, including a pharmacy and a public health clinic, and ask whether paying the full series upfront earns a discount.
Can I negotiate an HPV vaccine bill after the fact?
Yes. If an HPV vaccine bill arrives higher than expected, call the billing department, request an itemized bill, and ask for the self-pay discount most providers apply to uninsured patients, which is often 20 to 60 percent off the chargemaster price. A cash-pay-now offer can reduce the balance by 30 to 50 percent. Flag any copay that should have been $0 under the ACA. If the bill exceeded a written Good Faith Estimate by $400 or more, use the dispute process at cms.gov/nosurprisesact within 120 days instead of paying in full.
What's the difference between hospital and clinic or pharmacy HPV vaccine cost?
A retail pharmacy or public clinic charges about $0 to $450 per dose in 2026, while a hospital outpatient department can charge $400 to $600 per dose. The vaccine product is the same Gardasil 9 in every setting, and the CDC 2026 private-sector price is $329.09 per dose. The gap comes from hospital chargemaster pricing, possible facility fees, and added evaluation charges. Insured patients pay $0 at any in-network site, so the difference matters mainly for cash-pay patients, who should price a pharmacy or clinic before accepting a hospital quote.
Is the HPV vaccine covered by ACA preventive care?
Yes. ACA-compliant plans must cover the HPV vaccine in-network at $0 copay, coinsurance, and deductible for the ages ACIP recommends, which are routine at 11 to 12, catch-up through 26, and shared clinical decision-making for 27 to 45. The HPV vaccine is not a USPSTF-graded service, because ACIP governs vaccine coverage, but the no-cost-sharing rule in Section 2713 applies equally. Grandfathered plans and short-term plans may not follow this rule, so confirm with your insurer, especially for doses beyond what the plan's schedule recognizes.
What's the difference between the 2-dose and 3-dose HPV vaccine series cost?
A 2-dose series, used when vaccination starts before the 15th birthday, costs about $600 to $900 without insurance in 2026, while a 3-dose series, used for ages 15 and older and for immunocompromised patients, costs about $900 to $1,350. Each dose is the same Gardasil 9 vaccine at roughly $300 to $450. The CDC revised its childhood schedule in January 2026 to recommend one dose at age 11, which would cost about $300 to $450, but the FDA label and some medical societies still describe a multi-dose series. ACA-compliant plans cover recommended doses at $0.
Is the HPV vaccine covered for adults ages 27 to 45?
Yes, in most cases. ACIP recommends shared clinical decision-making for ages 27 to 45, meaning the patient and clinician decide together, and ACA-compliant plans cover vaccines in that category at $0 in-network. Medicaid and Medicare Part D plans also cover recommended adult vaccines without cost-sharing in 2026. Without insurance, an adult in this group needs 3 doses at about $300 to $450 each. Ask your clinician to document the shared decision, since a missing note is a common reason for a claim denial, and ask about the Merck patient assistance program if you are uninsured.
